Invasive Aspergillosis
📧 Sign up to get email alerts when something new happens for Invasive Aspergillosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-02-19FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for Vfend (voriconazole) submitted by Roerig.
-
FDA approval · 2026-01-28FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig.
-
FDA approval · 2025-11-14FDA Approved: VORICONAZOLE — Original Application (Hainan Poly Pharm. Co., Ltd.)
The FDA approved a generic Voriconazole product from Hainan Poly Pharm. Co., Ltd. via an Original Application (ANDA 220043). It covers voric…
-
FDA approval · 2025-07-18FDA Approved: CASPOFUNGIN ACETATE — Original Application (Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.)
The FDA approved Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.'s caspofungin acetate as an original generic application (ANDA) for mark…
-
FDA approval · 2025-07-03FDA Approved: POSACONAZOLE — Supplemental Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved a supplemental application for posaconazole submitted by Glenmark Pharmaceuticals Inc., USA, under an ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-24FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) from Astellas Pharma US, Inc.
-
FDA approval · 2025-03-24FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for CRESEMBA (isavuconazonium sulfate) filed by Astellas Pharma US, Inc.
-
FDA approval · 2025-03-13FDA Approved: POSACONAZOLE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for posaconazole from Mylan Institutional LLC, updating the approval for the generic product.
-
EMA approval · 2025-01-21EMA Authorised: Posaconazole AHCL (posaconazole) — Accord Healthcare S.L.U.
EMA authorised Posaconazole AHCL by Accord Healthcare S.L.U. for mycoses. The EU marketing authorization was granted on 16 January 2025.
-
FDA approval · 2024-12-23FDA Approved: POSACONAZOLE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' posaconazole under an Original Application (ANDA), marking a generic approval for this antifungal.
-
FDA approval · 2024-10-25FDA Approved: NOXAFIL — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for NOXAFIL (posaconazole) from Merck Sharp & Dohme LLC.
-
FDA approval · 2024-10-24FDA Approved: POSACONAZOLE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for posaconazole (POSACONAZOLE), approving the generic product.
-
FDA approval · 2024-04-03FDA Approved: VORICONAZOLE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for Voriconazole (generic), confirming its status as an approved generic antifunga…
-
FDA approval · 2023-12-26FDA Approved: POSACONAZOLE — Original Application (Mylan Institutional LLC)
FDA approves a generic posaconazole product from Mylan Institutional LLC under an Original Application (ANDA 211500). The approval indicates…
-
FDA approval · 2023-12-08FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) from Astellas Pharma US, Inc.
-
FDA approval · 2023-12-08FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for CRESEMBA (isavuconazonium sulfate) submitted by Astellas Pharma US, Inc. The approval updates th…
-
FDA approval · 2023-08-28FDA Approved: POSACONAZOLE — Original Application (i3 Pharmaceuticals, LLC)
FDA approved an original application for posaconazole from i3 Pharmaceuticals, LLC (generic posaconazole).
-
FDA approval · 2023-08-08FDA Approved: VORICONAZOLE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for voriconazole from Zydus Lifesciences Limited, indicating an approval of the supplemental submiss…
-
FDA approval · 2023-03-09FDA Approved: VORICONAZOLE — Original Application (UBI Pharma Inc.)
FDA approved a generic version of voriconazole (UBI Pharma Inc.) via Original Application. The approval covers treatment of certain invasive…
-
FDA approval · 2022-12-14FDA Approved: VORICONAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Voriconazole from Sandoz Inc, approving a generic version of the antifungal medication.
-
FDA approval · 2022-12-08FDA Approved: POSACONAZOLE — Original Application (NorthStar RxLLC)
The FDA approved NorthStar RxLLC's original application for posaconazole, granting authorization for a generic posaconazole product (ANDA 21…
-
FDA approval · 2022-08-16FDA Approved: VORICONAZOLE — Supplemental Application (Xellia Pharmaceuticals USA LLC)
FDA approved a supplemental application for Voriconazole by Xellia Pharmaceuticals USA LLC.
-
FDA approval · 2022-07-28FDA Approved: POSACONAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for posaconazole delayed-release (POSACONAZOLE DELAYED-RELEASE) from Chartwell RX, LLC, updating its…
-
FDA approval · 2022-06-13FDA Approved: VORICONAZOLE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Voriconazole from Zydus Lifesciences Limited, updating the approval for this generic antifun…
-
FDA approval · 2022-05-25FDA Approved: POSACONAZOLE — Original Application (Par Health USA, LLC)
FDA approved the original application for posaconazole (generic) by Par Health USA, LLC, marking the availability of a generic posaconazole …